Nasus Pharma Ltd. (NYSEAMERICAN:NSRX – Get Free Report) shares were down 0.3% during trading on Thursday . The company traded as low as $3.01 and last traded at $3.07. Approximately 15,639 shares changed hands during mid-day trading, a decline of 67% from the average daily volume of 46,690 shares. The stock had previously closed at $3.08.
Wall Street Analyst Weigh In
Separately, Citizens Jmp dropped their target price on Nasus Pharma from $19.00 to $18.00 and set a “market outperform” rating for the company in a research report on Thursday, March 26th. One equities research analyst has rated the stock with a Buy rating, According to MarketBeat, Nasus Pharma currently has an average rating of “Buy” and an average price target of $18.00.
Check Out Our Latest Research Report on Nasus Pharma
Nasus Pharma Stock Performance
About Nasus Pharma
Nasus Pharma Ltd. is a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions. Nasus Pharma Ltd. is based in TEL AVIV, Israel.
Featured Articles
- Five stocks we like better than Nasus Pharma
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for Nasus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nasus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
